Arman Altincatal

Impact of Delayed Appropriate Antibiotic Therapy on Patient Outcomes by Antibiotic Resistance Status From Serious Gram-negative Bacterial Infections

Nicole Bonine, Ariel Berger, Arman Altincatal et al. · The American Journal of the Medical Sciences · 2018 · 131 citations · Full text

COVID-19 in Patients with Multiple Sclerosis: Associations with Disease-Modifying Therapies

Anthony T. Reder, Diego Centonze, Maria L. Naylor et al. · CNS Drugs · 2021 · 120 citations · Full text

Effects of maternal breathing rate, psychiatric status, and cortisol on fetal heart rate

Catherine Monk, William P. Fifer, Michael M. Myers et al. · Developmental Psychobiology · 2010 · 62 citations · Full text

Responder definition of the Multiple Sclerosis Impact Scale physical impact subscale for patients with physical worsening

Glenn Phillips, Kathleen W. Wyrwich, Shien Guo et al. · Multiple Sclerosis Journal · 2014 · 58 citations · Full text

Antimicrobial Resistance or Delayed Appropriate Therapy—Does One Influence Outcomes More Than the Other Among Patients With Serious Infections Due to Carbapenem-Resistant Versus Carbapenem-Susceptible Enterobacteriaceae?

Thomas P. Lodise, Ariel Berger, Arman Altincatal et al. · Open Forum Infectious Diseases · 2019 · 47 citations · Full text